Heartcore Enterprises, Inc. (HTCR) Stock Price & Analysis
Heartcore Enterprises, Inc. (HTCR) fell 3.29% to USD 2.18 as of July 25, 2026 at 06:55 UTC, according to Nexqual real-time market data.
HTCR last closed at USD 2.25; the session ranged USD 2.18–2.33 on volume of 22,698 shares. Market capitalization is $3.14M, with a 52-week range of USD 2.18–33.4 (NCM). Source: Nexqual, July 25, 2026 at 06:55 UTC.
Key Statistics (as of July 25, 2026 at 06:55 UTC)
| Price | USD 2.18 |
|---|---|
| Change | ▼ 3.29% (down) |
| Previous Close | USD 2.25 |
| Open | USD 2.29 |
| Day Range | USD 2.18 – 2.33 |
| 52-Week Range | USD 2.18 – 33.4 |
| Volume | 22,698 shares |
| Market Cap | $3.14M |
| Exchange | NCM |
Technical Analysis (HTCR)
Nexqual's technical model rates HTCR "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 06:55 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 29.18 (oversold) |
| vs SMA50 | Below (USD 3.03) |
| MACD | -0.24 (negative) |
Analyst Ratings (HTCR)
Wall Street analysts rate HTCR "None", per Nexqual as of July 25, 2026 at 06:55 UTC.
| Consensus Rating | None |
|---|
Earnings (HTCR)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-06-30 | USD 0.8 vs est -1.6 ▲ beat |
| 2025-03-31 | USD -2.8 vs est -0.2 ▼ miss |
Source: Nexqual, July 25, 2026 at 06:55 UTC.
Financials & Fundamentals (HTCR)
| Total Revenue | $8.12M |
|---|---|
| Revenue Growth (YoY) | -40.50% |
| Gross Margin | +33.02% |
| Operating Margin | -123.65% |
| Profit Margin | +86.31% |
| ROE | -105.41% |
| Debt / Equity | 24.65 |
| Current Ratio | 1.17 |
| Total Cash | $4.17M |
| Total Debt | $1.30M |
| Free Cash Flow | $-2.36M |
Source: Nexqual, July 25, 2026 at 06:55 UTC.
Financial Health Score (HTCR)
Nexqual rates Heartcore Enterprises, Inc.'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 06:55 UTC.
| Growth | Strong — Revenue +39% YoY (annual) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Strong — $4M cash vs $1M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$2M, burning cash |
| Efficiency | Critical — ROE -105%, ROA -19.7% |
Ownership (HTCR)
| Insider Ownership | +50.63% |
|---|---|
| Institutional Ownership | +0.93% |
| Shares Outstanding | 1.44M |
| Float | 557,208 |
| Short % of Float | +3.75% |
Source: Nexqual, July 25, 2026 at 06:55 UTC.
Leadership (HTCR)
Heartcore Enterprises, Inc. is led by Sumitaka Yamamoto (age 59), President, CEO & Chairman, per Nexqual as of July 25, 2026 at 06:55 UTC.
| President, CEO & Chairman | Sumitaka Yamamoto (age 59) |
|---|---|
| COO & Director | Kimio Hosaka (age 56) |
| Chief Financial Officer | Qizhi Gao (age 43) |
Major Backers & Investors (HTCR)
Notable institutional backers of Heartcore Enterprises, Inc. include Board Of Trustees Of The Leland Stanford Junior University, Xtx Topco Ltd, according to Nexqual as of July 25, 2026 at 06:55 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Board Of Trustees Of The Leland Stanford Junior University | 0.35% |
| Xtx Topco Ltd | 0.11% |
Source: Nexqual, July 25, 2026 at 06:55 UTC.
From Heartcore Enterprises, Inc.'s Latest SEC 10-K Filing (filed 2026-03-31)
Key Strengths & Strategy (as disclosed to the SEC)
- We specialize in providing end-to-end advisory and execution support to companies navigating the transition from Japanese domestic standards to the regulatory, financial reporting, and governance requirements applicable to U.S. public companies.   Unlike traditional software-driven sales models, our go-to-market approach is relationship-driven and highly targeted.
- Our partnerships enable us to maintain a steady pipeline of potential clients and enhance our ability to deliver integrated solutions across legal, financial, and operational domains.   Our marketing efforts are focused on establishing thought leadership and building credibility within our target market.
Partnerships
- In connection therewith, in addition to the HeartCore Japan Sale, which closed on October 31, 2025, the Company is assessing all strategic alternatives to divest its 51% equity interest in Sigmaways, Inc. to a third party.   As of the date of this report, the Company has not entered into a definitive agreement with respect to a sale of its equity interest in Sigmaways.
- We consider our relations with our employees to be good.       Government Regulation   Investment Company Act of 1940   Our GO IPO business assists companies in navigating the IPO process in the U.S. markets.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ILAG | Intelligent Living Application | USD 3.45 | ▼ 0.23% |
| JCSE | JE Cleantech Holdings Limited | USD 1.36 | ▼ 2.86% |
| HSCS | HeartSciences Inc. | USD 2.39 | ▼ 4.4% |
| FRGT | Freight Technologies, Inc. | USD 3.01 | ▼ 15.45% |
| REVB | Revelation Biosciences, Inc. | USD 1.06 | ▼ 7.83% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 06:55 UTC. This page is informational and not investment advice.